GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jeisys Medical Inc (XKRX:287410) » Definitions » EV-to-EBITDA

Jeisys Medical (XKRX:287410) EV-to-EBITDA : 22.34 (As of Jun. 03, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Jeisys Medical EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Jeisys Medical's enterprise value is ₩964,386 Mil. Jeisys Medical's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was ₩43,165 Mil. Therefore, Jeisys Medical's EV-to-EBITDA for today is 22.34.

The historical rank and industry rank for Jeisys Medical's EV-to-EBITDA or its related term are showing as below:

XKRX:287410' s EV-to-EBITDA Range Over the Past 10 Years
Min: 0.25   Med: 22.12   Max: 145.81
Current: 22.34

During the past 7 years, the highest EV-to-EBITDA of Jeisys Medical was 145.81. The lowest was 0.25. And the median was 22.12.

XKRX:287410's EV-to-EBITDA is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 15.61 vs XKRX:287410: 22.34

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-06-03), Jeisys Medical's stock price is ₩12900.00. Jeisys Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was ₩360.000. Therefore, Jeisys Medical's PE Ratio (TTM) for today is 35.83.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Jeisys Medical EV-to-EBITDA Historical Data

The historical data trend for Jeisys Medical's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeisys Medical EV-to-EBITDA Chart

Jeisys Medical Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial 17.42 1.18 33.32 15.64 19.20

Jeisys Medical Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.41 23.09 19.20 14.10 22.31

Competitive Comparison of Jeisys Medical's EV-to-EBITDA

For the Medical Devices subindustry, Jeisys Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jeisys Medical's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jeisys Medical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Jeisys Medical's EV-to-EBITDA falls into.


;
;

Jeisys Medical EV-to-EBITDA Calculation

Jeisys Medical's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=964385.610/43165.272
=22.34

Jeisys Medical's current Enterprise Value is ₩964,386 Mil.
Jeisys Medical's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩43,165 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jeisys Medical  (XKRX:287410) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Jeisys Medical's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=12900.00/360.000
=35.83

Jeisys Medical's share price for today is ₩12900.00.
Jeisys Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩360.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Jeisys Medical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Jeisys Medical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Jeisys Medical Business Description

Traded in Other Exchanges
N/A
Address
76 Eulji-ro, Jung-gu, Seoul, KOR, 04538
Jeisys Medical Inc is a medical device manufacturer that produces high-end products for plastic surgeons, dermatologists, physicians, and healthcare professionals. Some of its products include ULTRAcel Q+ system, Cellec V system, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, and SmoothCool.

Jeisys Medical Headlines

No Headlines